IBU Prescription Ibuprofen Tablets Recalled for Failed Impurity Specifications
Dr. Reddy's Laboratories is recalling 31,802 bottles of IBU Ibuprofen 600mg tablets due to failed impurity specifications. The product was distributed nationwide and in Puerto Rico.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II pharmaceutical recall for impurity specification failures. Without reported illnesses or injuries documented, the severity rating is High per the rubric rather than Severe.
Plain-English summary
Dr. Reddy's Laboratories, Inc. is recalling IBU Ibuprofen 600mg tablets (Rx Only) due to impurity specification failures. Approximately 31,802 bottles distributed throughout the United States and Puerto Rico are affected.
Impurity testing revealed unknown compounds at 0.13% and 0.11%, exceeding the 0.10% specification limit. This represents a manufacturing quality-control failure. The recall affects two NDC numbers: 55111-683-01 (100-tablet bottles) and 55111-683-05 (500-tablet bottles).
Specific lot numbers and expiration dates are available from the FDA and Dr. Reddy's Laboratories to help identify affected product. Consumers and healthcare providers should check these resources to determine if their product is affected. Patients currently taking this medication should contact their healthcare provider or pharmacist for guidance before taking any action, as abrupt discontinuation should be discussed with a healthcare professional.
This is an FDA Class II recall.
The recalled product
- Product
- IBU (IBUPROFEN)
- Brand
- IBU
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Category
- Drug
- Hazard
- unknown-impurity
- degradation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (14)
- a)NDC 55111-683-01 Lots C2207527
- Exp 5/31/2026
- C2210864
- Exp 9/30/2026
- C2213018
- Exp 11/30/2026. b)NDC 5511-683-05 Lots C2207528
- C2210860
- C2213016
- C2213017
- Exp 11/30/2026
- C2301852
- C2302056
- C2302057
- Exp 1/31/2027.
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · IBU
- LowIbuprofen 600 mg tablets recalled for failed tablet specifications
FDA (Drugs) · 2024-11-27
- HighPrescription Ibuprofen Recalled Due to Failed Impurity Specifications
FDA (Drugs) · 2024-09-04
- HighPrescription Ibuprofen Tablets Recalled for Excessive Unknown Impurities
FDA (Drugs) · 2024-09-04
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27